2-acetamido-1,5-imino-1,2,5-trideoxy-d-glucitol has been researched along with homonojirimycin in 1 studies
| Studies (2-acetamido-1,5-imino-1,2,5-trideoxy-d-glucitol) | Trials (2-acetamido-1,5-imino-1,2,5-trideoxy-d-glucitol) | Recent Studies (post-2010) (2-acetamido-1,5-imino-1,2,5-trideoxy-d-glucitol) | Studies (homonojirimycin) | Trials (homonojirimycin) | Recent Studies (post-2010) (homonojirimycin) |
|---|---|---|---|---|---|
| 8 | 0 | 2 | 15 | 0 | 7 |
| Protein | Taxonomy | 2-acetamido-1,5-imino-1,2,5-trideoxy-d-glucitol (IC50) | homonojirimycin (IC50) |
|---|---|---|---|
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | 0.04 | |
| Lysosomal acid glucosylceramidase | Homo sapiens (human) | 1 | |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | 0.55 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.26 | |
| Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | 0.435 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 1 | |
| Glycogen debranching enzyme | Oryctolagus cuniculus (rabbit) | 0.11 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Lysosomal alpha-glucosidase | Rattus norvegicus (Norway rat) | 1.6583 | |
| Neutral alpha-glucosidase C | Mus musculus (house mouse) | 0.34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, ER; Boyd, RE; Khanna, R; Lee, G; Rybczynski, P; Valenzano, KJ; Wustman, BA | 1 |
1 review(s) available for 2-acetamido-1,5-imino-1,2,5-trideoxy-d-glucitol and homonojirimycin
| Article | Year |
|---|---|
Pharmacological chaperones as therapeutics for lysosomal storage diseases.
Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity Relationship | 2013 |